Dr. Pinski is a research-oriented medical oncologist, who received his clinical training at the Johns Hopkins Oncology Center in Baltimore, MD. He obtained his research training in the laboratory of the Nobel Prize laureate, Dr. Andrew Schally, at the Tulane University in New Orleans, LA, and in Dr. John Isaacs’ laboratory at Johns Hopkins in Baltimore.
In the past, he studied extensively the role of hypothalamic/pituitary hormones like LH-RH and LH, hormone analogues (such as LH-RH antagonists) as well as neuroendocrine differentiation in prostate cancer. This research work resulted in more than 80 publications and research funding from the DOD, NCI and ACS. His laboratory is presently studying the regulation of steroid synthesis in prostate cancer by hormones of the hypothalamic/pituitary axis and the prognostic value of novel molecular markers for clinical outcomes in patients with prostate cancer.